| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 25, 2025 | Mar 27, 2025 | Prelude Therapeutics Inc | Chief Chemistry Officer | Buy | 95.0 | +100,000 | 26.31% | ✗ | $69.3K |
| Dec 20, 2024 | Dec 26, 2024 | Prelude Therapeutics Inc | Chief Chemistry Officer | Buy | 95.0 | +63,075 | 20.05% | ✗ | $85.5K |
| Dec 13, 2021 | Dec 15, 2021 | Prelude Therapeutics Inc | EVP, Head of Chemistry | Buy | 87.5 | +8,000 | 3.07% | ✗ | $94.9K |
| Sep 29, 2020 | Sep 29, 2020 | Prelude Therapeutics Inc | EVP, Head of Chemistry | Buy | 61.3 | +1,000 | 0.39% | ✗ | $19K |